Philip B. Wedegaertner, PhD
Professor
Contact Information
Professor
Expertise & Research Interests
To function properly, intracellular signaling pathways depend upon appropriate and unique subcellular locations of their constituent proteins. Research in the Wedegaertner lab focuses on understanding cellular mechanisms of G protein signaling. Heterotrimeric G proteins are well known for their function in linking G protein-coupled receptors (GPCRs) to a variety of intracellular responses. In the textbook view, G proteins carry out their function while associated with the cytoplasmic surface of a cell’s plasma membrane (PM). In contrast to PM-limited G protein signaling, it has become increasing clear that G proteins can have important cellular functions at diverse intracellular sites. A major focus of the lab is to understand mechanisms that regulate membrane binding and trafficking to distinct subcellular locations for G proteins, and other signaling proteins, and to understand novel signaling functions at different subcellular locations.
Signaling by G Protein beta-gamma subunits at the Golgi
One research area in the lab addresses a recently appreciated non-canonical G protein function: the role of beta-gamma in regulating Golgi function and integrity. The Golgi is an essential organelle in directing the transport of secretory and plasma membrane (PM) proteins, as well as transport to other organelles. It has been estimated that one-third of the human proteome traverses the secretory pathway – from synthesis at the endoplasmic reticulum (ER), through the ER and Golgi apparatus, and then ultimately transport via vesicles or larger transport carriers to the PM or to intracellular organelles. Proper transport of transmembrane proteins to the PM and proper secretion of proteins is universally essential for cell function. Moreover, numerous disease states result from dysregulation of protein transport. Using a variety of cell biology techniques, including the development of novel tools for inducible recruitment of G proteins or G protein regulators to specific subcellular organelles, our lab has defined a role for signaling by beta-gamma subunits at the Golgi in regulating protein transport. In addition, the Golgi is a dynamic organelle that undergoes reversible breakdown (i.e., fragmentation and dispersal) under normal physiological conditions in cells, as well as in pathophysiological conditions, such as infection, cancer and neurodegenerative disease. Thus, our work is also addressing an unexpected role for beta-gamma subunits in regulating changes in Golgi morphology.
Signaling by mutant G alpha q/11 subunits in uveal melanoma
Uveal melanoma is the most common cancer of the eye in adults. In up to 50% of cases, uveal melanoma metastasizes to the liver, and patient survival is extremely low; no effective therapies have been developed for metastatic uveal melanoma. Strikingly, more than 90% of uveal melanomas harbor mutually exclusive activating mutations in the closely related heterotrimeric G protein alpha subunits G alpha q or G alpha 11. Mutation in G alpha q or G alpha 11 is an early event in uveal melanoma and is thus considered a driver mutation for this cancer. Our focus is to understand how mutational activation disrupts subcellular localization and dysregulates signaling of G alpha q or G alpha 11 and to understand the mechanisms that govern intracellular trafficking of mutationally activated G alpha q or G alpha 11. By understanding the unique subcellular trafficking mechanisms of mutationally activated G alpha q or G alpha 11 in uveal melanoma cells, we hope to define novel therapeutic targets for disrupting trafficking and signaling by these mutationally activated G proteins.
Education
PhD, University of California, San Diego, Biochemistry - 1991
Most Recent Peer-Reviewed Publications
- Going Rogue: Mechanisms, Regulation, and Roles of Mutationally Activated Ga in Human Cancer
- Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth
- Gβγ signaling regulates microtubule-dependent control of Golgi integrity
- Disruption of the interaction between mutationally activated Gαq and Gβγ attenuates aberrant signaling
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890